Inherited gene variation leaves young leukemia patients at risk for peripheral neuropathy

24 febrero 2015

Researchers have identified the first genetic variation that is associated with increased risk and severity of peripheral neuropathy following treatment with a widely used anti-cancer drug. Investigators also found evidence of how it may be possible to protect young leukemia patients without jeopardizing cures.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/TA3D_OzA7Fw/150224120915.htm